📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. (2011)

First Author: Baigent C

Attributed to: CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(11)60739-3

PubMed Identifier: 21663949

Publication URI: http://europepmc.org/abstract/MED/21663949

Type: Journal Article/Review

Volume: 377

Parent Publication: Lancet (London, England)

Issue: 9784

ISSN: 0140-6736